Project Details
Description
A Randomized, Double-blind, Placebo-controlled Phase 2 Study with Open-label Extension to Assess the Efficacy and Safety of Namilumab in Subjects with Chronic Pulmonary Sarcoidosis
| Status | Active |
|---|---|
| Effective start/end date | 12/1/21 → 6/30/25 |
Funding
- KINEVANT SCIENCES, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.